Found 5 matching trials
Treatment De-Escalation for Favorable Prognosis Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer Receiving Definitive Radiotherapy NA The current standard treatment option for Human Papillomavirus (HPV) or p16...
Show More Location
Medstar Georgetown University Hospital
Learn More & Join Trial
A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze) PHASE2 Single center, non-randomized Phase II study enrolling Stage I-II p16+ orop...
Show More Location
University of Michigan Rogel Cancer Center
Learn More & Join Trial
A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED) PHASE2 Patients with human papillomavirus (HPV)-related oropharyngeal cancer gener...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma PHASE1 The purpose of this research study is to see if it is feasible to combine a...
Show More Location
University of Miami
Learn More & Join Trial
Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma PHASE2 The purpose of this study is to demonstrate that participants with HPV posi...
Show More Status
Active Not Recruiting
Location
Hartford Healthcare (Data Collection)
Learn More & Join Trial